Investors Video and Audio

video

Shield Therapeutics ‘seeking to conclude US partnering discussions’

Jan 2020 - 9:18
audio

Tim Watts, CFO, Shield Therapeutics (STX) provides an update outlining progress during 2019 which included the FDA approval of lead product, Feraccru®/Accrufer®.

Jan 2020 - 20:49
video

Shield Therapeutics ties up US$63million deal for Feraccru in China

Jan 2020 - 6:32
audio

Shield Therapeutics discuss their Chinese licencing agreement plus John Meyer on Sirius and Arc Minerals

Jan 2020 - 23:30
video

Investival Showcase Presentations 2019 – Shield Therapeutics

Dec 2019 - 16:15
video

Dr Mark Sampson, CMO discusses Feraccru and data presented at UEG Week 2019

Oct 2019 - 6:18
video

Shield Therapeutics to present data showing Feraccru offers ‘real oral alternative’

Oct 2019 - 6:09
video

Tim Watts, CFO at Shield Therapeutics #STX presenting at our Life Sciences Investor Briefing

Sep 2019 - 28:21
audio

Interim results for the six months ended 30 June 2019

Aug 2019 - 50:49
video

Shield Therapeutics ‘in a strong position’ and confident of a US Feraccru deal

Aug 2019 - 7:31
audio

Elevator Pitches Reabold Resources, Block Energy and Shield Therapeutics

Aug 2019 - 36:00
video

Q&A with CEO of Shield Therapeutics (STX) Carl Sterritt

Aug 2019 - 9:04